Venous thromboembolism (VTE) rates following the implementation of extended duration prophylaxis for patients undergoing surgery for gynecologic malignancies.

[1]  V. Dandolu,et al.  Prolonged postoperative venous thrombo-embolism prophylaxis is cost-effective in advanced ovarian cancer patients. , 2012, Gynecologic oncology.

[2]  P. Ramirez,et al.  Patient cost associated with filling a prescription for extended-duration venous thromboembolism (VTE) prophylaxis following surgery for gynecologic cancer. , 2012, Gynecologic oncology.

[3]  A. Turpie,et al.  Semuloparin for thromboprophylaxis in patients receiving chemotherapy for cancer. , 2012, The New England journal of medicine.

[4]  Michael K Gould,et al.  Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.

[5]  A. Neugut,et al.  Quality of Perioperative Venous Thromboembolism Prophylaxis in Gynecologic Surgery , 2011, Obstetrics and gynecology.

[6]  A. Berchuck,et al.  Cost comparison of strategies for the management of venous thromboembolic event risk following laparotomy for ovarian cancer. , 2011, Gynecologic oncology.

[7]  Shing M. Lee,et al.  Quality of Venous Thromboembolism Prophylaxis in Patients Undergoing Oncologic Surgery , 2011, Annals of surgery.

[8]  A. Weaver,et al.  Incidence and timing of venous thromboembolism after surgery for gynecological cancer. , 2011, Gynecologic oncology.

[9]  Caimiao Wei,et al.  Risk of Thromboembolic Disease in Patients Undergoing Laparoscopic Gynecologic Surgery , 2010, Obstetrics and gynecology.

[10]  S. Barni,et al.  Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study. , 2009, The Lancet. Oncology.

[11]  D. Kushner,et al.  A Protocol of Dual Prophylaxis for Venous Thromboembolism Prevention in Gynecologic Cancer Patients , 2008, Obstetrics and gynecology.

[12]  Judy L. Smith,et al.  Venous thromboembolic disease. NCCN. Clinical practice guidelines in oncology. , 2008, Journal of the National Comprehensive Cancer Network : JNCCN.

[13]  Gary H Lyman,et al.  American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  J. Lancaster,et al.  Defining practice patterns in gynecologic oncology to prevent pulmonary embolism and deep venous thrombosis. , 2007, Gynecologic oncology.

[15]  Gynecologists.  ACOG Practice Bulletin No. 84: Prevention of deep vein thrombosis and pulmonary embolism. , 2007, Obstetrics and gynecology.

[16]  J. Lancaster,et al.  Pulmonary Embolism After Major Abdominal Surgery in Gynecologic Oncology , 2006, Obstetrics and Gynecology.

[17]  A. Shillington,et al.  Antithrombotic therapy practices in US hospitals in an era of practice guidelines. , 2005, Archives of internal medicine.

[18]  L. Melton,et al.  Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study. , 2002, Archives of internal medicine.

[19]  A. Cohen,et al.  Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. , 2002, The New England journal of medicine.

[20]  D. Clarke-Pearson,et al.  The natural history of postoperative venous thromboemboli in gynecologic oncology: a prospective study of 382 patients. , 1984, American journal of obstetrics and gynecology.